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Abstract
Background: Currently, alternate plasticizers are used to replace phthalate plasticizers in children’s toys, medical
equipments and food packaging, due to the adverse effects of phthalate compounds on human health and laws
prohibiting their use. Current information regarding the safety and potential adverse effects of alternate plasticizers
is limited and recent studies have found alternate plasticizers to display similar characteristics to those observed in
phthalate plasticizers. This study was undertaken to evaluate and predict the potential endocrine disrupting activity
of the three most commonly used alternate plasticizers: di(2-ethylhexyl)terephthalate (DEHT), tris(2-ethylhexyl)
trimellitate (TOTM), and diisononyl hexahydrophthalate (DINCH) against human sex hormone-binding globulin
(SHBG) using in silico approaches.
Materials and methods: The crystal structure of human SHBG (Id: 1D2S) was retrieved from Protein Data Bank.
PubChem database was searched for the structures of alternate plasticizers, DEHT, TOTM, and DINCH. Docking was
performed using Glide (Schrodinger) Induced Fit Docking module.
Results: Induced Fit Docking of three alternate plasticizer compounds indicated that each of the three compounds
fitted well into the steroid binding pocket of SHBG. Docking displays showed interactions of alternate plasticizers
with 25–30 amino-acid residues of SHBG; 18–20 amino residues overlapped between the natural ligand, DHT, and
the three compounds (commonality of 82–91 %). The hydrogen-bonding interaction of the amino-acid residue,
Asn-82, of SHBG was also present in displays of DHT and all the three alternate phthalates. The binding affinity of all
the three alternate phthalates was higher than DHT; maximum in DINCH followed by TOTM and DEHT.
Conclusion: Our results suggested that the three alternate plasticizers have potential to engage the important
interacting residues of SHBG and thus interfere in its steroid homeostatic function.
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Background
Endocrine-disrupting chemicals (EDCs) are either syn-
thetic or natural heterogeneous compounds that are
ubiquitous in the environment and perturb hormonal
systems in human and animals [1–4]. Phthalate plasti-
cizers are one such group of synthetic chemicals
which have wide applications as softeners in polyvinyl
chloride plastics and are used in medical and surgical
equipments, consumer products, children’s toys, per-
sonal care, and common household products [5]. Ex-
posure to phthalates in children as well as in adult
men and women has been associated with many de-
velopmental and functional abnormalities of repro-
ductive system [6–9]. High volume production and
wide use of phthalates leads to widespread contamin-
ation in the environment and is therefore considered
as a global public health problem.
In view of the overwhelming evidence of the adverse
effects of phthalate plasticizers, the United States Con-
gress passed a law, Consumer Product Safety Improve-
ment Act of 2008, which has permanently banned six
most toxic phthalate compounds. The Congress further
mandated the convening of a Chronic Hazard Advisory
Panel (CHAP) to assess further phthalate plasticizers
and as of June 2015, additional phthalate compounds
have been added to the list of potential prohibitions.
Likewise, prohibitions on the use of phthalates have
been in place in the European Union since 2005. The
adverse health effects of phthalate plasticizers and prohi-
bitions on their use has led to increased efforts in the
development of alternative non phthalate compounds as
plasticizers in the industry [10, 11]. There are over a
dozen alternate compounds that have been used in the
industry until now. Three alternate plasticizers i.e., di(2-
ethylhexyl)terephthalate (DEHT), tris(2-ethylhexyl)tri-
mellitate (TOTM), and diisononyl hexahydrophthalate
(DINCH) are among the most commonly used. A higher
cost in comparison to traditional plasticizers is one of
the reasons that alternate phthalate plasticizers have not
become popular. In spite of this, demand has increased
over time with all the three aforementioned alternate
plasticizers listed as high production volume chemicals
for Organization of Economic Cooperation and Develop-
ment countries [11]. Given the history of adverse health
effects stemming from phthalate plasticizers, it is im-
perative that the alternate plasticizers are subjected to a
great deal of scrutiny from researchers. Studies on alter-
nate plasticizers are limited and in many cases have not
found severe adverse effects. However, in some recent
studies similar characteristics were found between the
banned phthalate plasticizers and the aforementioned al-
ternate plasticizers on the basis of toxicological (i.e.
LD50) and developmental toxicity (no observed adverse
effect levels) evaluation [12].
The alternate plasticizer DEHT is an isomer of di(2-
ethylhexyl)phthalate (DEHP) possessing para carboxylic
groups and is considered as a non-phthalate plasticizer
[13]. Experimental studies on DEHT have produced low
toxicity in rats, mice, and guinea pigs [14, 15]. Continu-
ous dietary exposure of rats to DEHT for 2 years also in-
dicated low levels of toxicity [16] with no evidence of
reproductive and developmental abnormalities [17–19].
Toxic responses at high doses included reduced weight
gain, lower food conversion efficiency, and an increase
in age-related retinal degeneration rate [16]. Continuous
intravenous infusion of rats with different doses of
DEHT for 4 weeks did not affect their survival, body
weight, and food and water consumption [20]. No hema-
totoxic and immunotoxic effects or histopathological le-
sions were found in the liver, thyroid or reproductive
system. In a preliminary clinical study [13], dermal appli-
cation of DEHT did not induce any adverse skin reac-
tion. A recent study [21] in the USA suggested that
DEHT was the most common plasticizer in children’s
backpacks and plastic toys. Analysis on dry and wet
wipes from the backpacks and toys indicated strong
correlations between mass transfer of DEHT and mass
content of DEHT in the products suggesting potential
for human exposure through skin [21].
Another alternate plasticizer, TOTM, is an ester of
trimellitic acid which is frequently used in medical equip-
ment in Japan. The differences in structure compared to
phthalate compounds lead to significant changes in the
migration and extraction characteristics of this plasticizer
[13, 22, 23]. TOTM has almost fully replaced DEPH in
platelet storage bags because of its superior gas exchange
properties [24]. Limited experimental toxicological studies
have been done on TOTM. TOTM was shown as a weak
estrogen in cell culture [25] and had hepatotoxic proper-
ties although lesser than DEHP [26]. Repeated dermal
patch tests in human subjects resulted in lower skin sensi-
tivity problems compared to phthalate compounds [27].
In rats, TOTM induced hepatic vascular congestion, lipid
globules in hepatocytes, with significantly decreased hep-
atocyte mitochondrial membrane antigen immune reac-
tion indicating liver toxicity [28]. Intravenous injection of
TOTM in mice induced upregulation of 694 genes and
downregulation of 974 genes in liver [29]. Further analyses
of 11 genes revealed that the functions of cell cycle path-
way, oxidative process and lipid metabolism were affected
during hepatotoxic effects of TOTM in mice.
DINCH is a cyclohexane derivative with very low migra-
tion properties, almost 10 times lower than DEHP [13,
30], and has the advantage of similar viscosity as that of
DEHP helping thus in avoiding significant changes on
blending with polyvinyl chloride [31]. DINCH is a fairly
recent alternate phthalate and is in use for blood tubes
and nutrient solution bags. Recent data reviewed by
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Scientific Committee on Emerging and Newly Identified
Health Risks (SCENIHR) showed that oral or dermal ad-
ministration of DINCH in rats induced low toxicity, and
continuous dietary exposure in rats for 28 days failed to
have any effects on reproductive organs [13, 32]. Add-
itionally, prenatal exposure and two generational tests did
not produce any reproductive toxic effects. A thyroid
weight increase associated with a repeated exposure for 2
years in rats was of concern and was attributed to liver
problems [32]. Analysis of DINCH metabolites in the
urine of adult volunteers in the United States with no
known exposure to DINCH revealed that the detection
rate increased from 0 % during 2000–2007 to 21 % in
2012 [33]. In another study in Germany on 300 urine sam-
ples from the German Environmental Specimen Bank,
DINCH metabolites were detected in 0 % samples during
1999–2003 but the percentage of detection increased sub-
sequently for 2006 (7), 2009 (43), and 2012 (98 %) [34]. A
recent study [35] in German daycare centers revealed that
DEHT and DINCH were present in 100 dust samples and
85 % of the air samples. Further, metabolites of DINCH
were detectable in 100 % of the urine samples of 203
tested children from these centers.
Owing to the increasing use and demand of alternate
plasticizers, there is an urgent need for exhaustive stud-
ies on their potential adverse effects on human health. It
is imperative that all possible methods including epi-
demiological, clinical, in vivo and in vitro experimental
approaches, and in silico predictive studies are utilized
to maximize the information on the potential health
effects of alternate plasticizers. Disruption of hormone
signaling pathways is commonly thought to be the
mechanism through which many of the environmental
contaminants exert their effects on human and animal
systems [1]. Sex hormone-binding globulin (SHBG) is a
high molecular weight steroid binding circulatory pro-
tein involved in maintaining the androgen and estrogen
homeostasis in the body [36]. The SHBG has also been
reported to bind with phthalates and other environmen-
tal contaminants [37–39] and, thus, is a potential target
for alternate plasticizer compounds in the body. Compu-
tational studies of alternate plasticizers with peroxisome
proliferating-activated receptors (PPARs) [40, 41] showed
no or weak interactions. Computational studies of alter-
nate plasticizers with nuclear receptors or steroid binding
carrier proteins are not available. SHBG was chosen
for in silico studies with alternate plasticizers in this
initial study based on our recent computational study
[42] that showed high binding affinity of SHBG with
phthalate plasticizers.
This study was undertaken to investigate the structural
binding characteristics of the three alternate plasticizers,
DEHT, TOTM, DINCH with SHBG using in silico ap-
proaches. It was expected that the computational systems
approach-derived binding mechanisms, the distinctive
binding pattern, and interacting residues of SHBG will
help in predicting potential endocrine disrupting risks of
the three alternate plasticizers which are already on the
market.
Methods
Schrodinger 2015 suite with Maestro 10.3 (graphical
user interface) software (Schrodinger, LLC, New York,
NY, 2015) was used for docking studies of DEHT,
TOTM, and DINCH with SHBG. The two dimensional
structures of the three alternate plasticizers are shown
(Fig. 1) and their abbreviations and PubChem compound
identities (CIDs) are presented (Table 1).
Protein selection and preparation
The Protein Data Bank (PDB; http://www.rcsb.org/) was
used to retrieve the crystal structure of human SHBG
(PDB code: 1D2S) at 1.55 Å. resolution. The SHBG was
co-complexed with its natural ligand, dihydrotestosterone
(DHT). The co-complex crystal structure was prepared by
protein preparation wizard workflow of Schrodinger after
importing it into the docking software, Glide (Schrodinger
suite 2015–3; Schrodinger, LLC). Removal of water mole-
cules and addition of hydrogen atoms in the crystal struc-
ture was followed by making loops and missing side
chains by Prime 3.0 module. Optimization of H-bond
particularly for Asp, Glu, and His hydroxyl containing res-
idues was done. Optimization of the hydrogen bonding
network was performed and OPLS_2005 force field was
used for a geometry optimization to a maximum root-
mean-square deviation (RMSD) of 0.30 Å. The bound
ligand, DHT in crystal complex was selected and used for
docking of DEHT, TOTM, and DINCH and grid boxes
were generated.
Ligand preparation and conformational search
Maestro 10.3 (Maestro, version 10.3, Schrodinger, LLC)
was used to draw ligand structures (Fig. 1). Ligands were
prepared using LigPrep module (Schrodinger 2015:
LigPrep, version 3.1, Schrodinger, LLC). Correct molecu-
lar geometries and ionize at biological pH 7.4 were
obtained by using the OPLS-2005 force field software.
Induced fit docking
Schrodinger’s Induced Fit Docking (IFD) module was
used for docking analyses of the three alternate plasti-
cizer compounds i.e. DEHT, TOTM, and DINCH.
LigPrep module was used to prepare the ligands and
were submitted as starting geometries to IFD. The IFD
has the ability of sampling the minor changes in the
backbone structure as well as robust conformational
changes in side chains [43]. A softened-potential docking
is performed in the first IFD stage where docking of the
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ligand occurs into an ensemble of the binding protein
conformations. Subsequently, complex minimization for
highest ranked pose is performed where both the ligand
and binding sites are free to move.
Binding energy calculations
The ligand binding affinity calculations against the crystal
complex was done using Prime module of Schrodinger
2015 with MMGB-SA function.
Results
Multiple docking poses were generated when the three
alternate phthalate compounds i.e. DEHT, TOTM, and
DINCH were subjected to docking simulation by suc-
cessful execution of IFD against the hormone binding
pocket of SHBG. The best pose for each of three com-
pounds was utilized for further computational analyses
(Figs. 2, 3 and 4). Similarly, the best pose of the bound
native ligand, DHT was used for analyses after the IFD
(Fig. 5).
Molecular docking of DEHT with SHBG
The DEHT docking complex with SHBG and corre-
sponding interacting amino-acid residues are shown
(Fig. 2). The docking complex shows that DEHT inter-
acted with 25 SHBG residues (Leu-34, Ile-37, Thr-40,
Ser-41, Ser-42, Phe-56, Gly-58, Thr-60, Trp-66, Phe-67,
Leu-80, Asn-82, Trp-84, Val-105, Lys-106, Met-107, Val-
112, Leu-113, Val-127, Ser-128, Gly-129, His-136, Met-
139, Ile-141, Leu-171) in the binding pocket of SHBG.
The DEHT formed a hydrogen bond against residue,
Asn-82 of SHBG (Fig. 2). The Dock score, Glide score,
and the binding affinity were similar to those of the
bound native ligand, DHT, with SHBG (Table 2).
The complex of natural ligand, DHT, and SHBG and
the corresponding interacting amino-acid residues are
shown (Fig. 5). The complex shows that 22 amino-acid
residues of SHBG (Thr-40, Ser-41, Ser-42, Phe-56, Gly-
58, Asp-59, Thr-60, Asp-65, Trp-66,Phe-67, Leu-80, His-
81, Asn-82, His-83, Val-105, Lys-106, Met-107, Val-112,
Ser-128, Met-139, ILe-141, Leu-171) interacted with
DHT. Residues Ser-42, Asp-65, and Asn-82 formed 3
hydrogen bonds with DHT. The comparison of the
docking complex of DEHT-SHBG with interacting resi-
dues of natural SHBG ligand, DHT, showed that 18
DEHT interacting residues overlapped.
Table 1 Nomenclature, commonly used abbreviations, and
PubChem IDs of the three alternate plasticizers for docking
study with human sex hormone-binding globulin (SHBG)
S.No. Name Abbreviation PubChem ID
1 Di(2-ethylhexyl)terephthalate DEHT 22932
2 Tris(2-ethylhexyl)trimellitate TOTM 18752
3 Diisononyl hexahydrophthalate DINCH 11524680
4 Dihydrotestosterone DHT 10635
Fig. 1 Two dimensional representation of three alternate phthalate ligands, di(2-ethylhexyl)terephthalate (DEHT), tris(2-ethylhexyl)trimellitate
(TOTM), and diisononyl hexahydrophthalate (DINCH), and natural ligand dihydrotestosterone (DHT)
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Molecular docking of TOTM with SHBG
The TOTM docking complex with SHBG and corre-
sponding interacting amino-acid residues are shown
(Fig. 3). The docking complex shows that TOTM inter-
acted with 30 SHBG residues (Leu-34, Thr-40, Ser-41,
Ser-42, Phe-56, Gly-58, Asp-59, Thr-60, Phe-67, Ile-78,
Leu-80, Asn-82, Trp-84, Val-105, Lys-106, Met-107,
Gly-109, Asp-110, Val-112, Ser-111, Leu-113, Val-127,
Ser-128, Leu-124, Gly-129, His-136, Met-139, Ile-141,
Trp-170, Leu-171) in the binding pocket of SHBG.
The TOTM formed a hydrogen bond against residue,
Asn-82 of SHBG (Fig. 3). The Dock score and Glide
score were lower, however, the binding affinity was higher
than that of the natural ligand, DHT, with SHBG (Table 2).
The comparison of the docking complex of TOTM-SHBG
with interacting residues of natural SHBG ligand, DHT,
showed that 18 DEHT interacting residues overlapped
(Fig. 5).
Molecular docking of DINCH with SHBG
The DINCH docking complex with SHBG and corre-
sponding interacting amino-acid residues are shown
(Fig. 4). The docking complex shows that DINCH inter-
acted with 30 SHBG residues (Leu-34, Thr-35, Lys-36,
Fig. 2 Ribbon form representation of docking complex of sex hormone-binding globulin (SHBG) with di(2-ethylhexyl)terephthalate (DEHT) (left panel).
Amino-acid residues in the binding pocket of SHBG involved in interactions with DEHT (right panel)
Fig. 3 Ribbon form representation of docking complex of sex hormone-binding globulin (SHBG) with tris(2-ethylhexyl)trimellitate (TOTM) (left panel).
Amino-acid residues in the binding pocket of SHBG involved in interactions with TOTM (right panel)
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Ile-37, Thr-38, Thr-40, Ser-41, Ser-42, Phe-56, Gly-58,
Asp-59, Thr-60, Asp-65,Trp-66, Phe-67, Leu-80, Asn-82,
Trp-84, Val-105, Lys-106, Met-107, Val-112, Leu-113,
Val-127, Ser-128, Gly-129, His-136, Met-139, ILe-141,
Leu-171) in the binding pocket of SHBG. The DINCH
formed two hydrogen bonds with residues, Asn-82 and
Ser-128 of SHBG (Fig. 4). The Dock score and Glide
score were lower, however, the binding affinity was
higher than that of the natural ligand, DHT, with SHBG
(Table 2). The comparison of the docking complex of
TOTM-SHBG with interacting residues of natural SHBG
ligand, DHT, showed that 20 DEHT interacting residues
overlapped (Fig. 5).
Comparison among Ligands
The IFD complexes of the three alternate phthalates i.e.,
DEHT, TOTM, and DINCH with SHBG showed interac-
tions with 25–30 amino-acid residues (indicated above
for each ligand). There were 18–20 amino residues over-
lapping between the natural ligand, DHT, and the three
alternate phthalate compounds (commonality of 82–91 %;
Table 2). Seventeen amino-acid residues of SHBG (Thr-40,
Fig. 4 Ribbon form representation of docking complex of sex hormone-binding globulin (SHBG) with diisononyl hexahydrophthalate
(DINCH) (left panel). Amino-acid residues in the binding pocket of SHBG involved in interactions with DINCH (right panel)
Fig. 5 Overall all ribbon form representation of sex hormone-binding globulin (SHBG) co-complex with natural ligand, dihydrotestosterone
(DHT) (left panel). Amino-acid residues in the binding pocket of SHBG involved in interactions with DHT (right panel)
The Author(s) BMC Structural Biology 2016, 16(Suppl 1):15 Page 16 of 20
Ser-41, Ser-42, Phe-56, Gly-58, Thr-60, Phe-67, Leu-80,
Asn-82, Val-105, Lys-106, Met-107, Val-112, Ser-128, Met-
139, ILe-141, Leu-171) were overlapping among the DHT
and all the three alternate phthalates (Table 3). Addition-
ally, two amino residues were overlapping among DHT
and 2 of the 3 alternate phthalates (Table 3). The hydrogen
bonding interaction of the amino-acid residue, Asn-82, of
SHBG was also present in displays of DHT and all the
three alternate phthalates. Five SHBG interacting residues
(Trp-84, Leu-113, Val-127, Gly-129, and His-136) were
common among the three alternate phthalates but not for
DHT. The Dock score and Glide score were highest in
DHT and progressively decreased for DINCH, TOTM, and
DEHT. However, the binding affinity of all the three alter-
nate phthalates was higher than DHT; maximum in
DINCH followed by TOTM and DEHT (Table 2).
Discussion
Human SHBG is an androgen and estrogen binding
circulatory protein synthesized in liver [36, 44]. The
majority of plasma dihydrotestosterone, testosterone,
and estradiol are bound to SHBG which maintains their
bioavailability equilibrium and protects them from meta-
bolic degradation [36]. Only a minor (1–3 %) portion of
the steroid hormones are in free form in the plasma and
this free form is considered bioavailable or “active” form
for the target receptors.
The IFD of three alternate plasticizer compounds with
human SHBG in this study indicated that each of the
three compounds fitted well into the steroid binding
pocket of SHBG. The high dock scores and high binding
affinity values indicated that the docking complexes of
the alternate plasticizer compounds and SHBG were in
their most favorable conformation. The docking analyses
revealed that several important SHBG residues exerted
hydrophobic and hydrogen-bonding interactions with
each of the alternate plasticizer compounds and con-
tributed to the stability of the docking complex. About
82–91 % of the SHBG interacting residues for the bound
ligand, DHT, overlapped with SHBG interacting residues
for the three alternate plasticizers, which suggested
structural similarity to a common steroid scaffold and
explained the binding of the compounds to the steroid
binding pocket of SHBG. Seventeen interacting residues
of SHBG and hydrogen bonding interaction with residue
Asn-82 were common among the DHT and each of the
three alternate phthalates. The high commonality of the
SHBG interacting residues between native ligand, DHT,
and three alternate plasticizers together with high dock
score and high binding affinity suggested high potential
for interference with the native steroid to SHBG binding
function. The three alternate plasticizers i.e. DEHT,
TOTM, and DINCH showed high binding affinity with
SHBG that was higher than that for the native bound lig-
and, DHT, indicating more tight interactions with the
SHBG. This suggested that the indicated alternate plasti-
cizers bound to the steroid binding site of the SHBG more
tightly than the native ligand, DHT, and thus each of the
alternate plasticizers has potential to inhibit the steroid
binding function of SHBG strongly by engaging the im-
portant residues. Therefore, these alternate plasticizers, on
Table 2 Number of interacting residues, number and percentage of residues common with dihydrotestosterone (DHT), Dock score,
Glide score and binding affinity values (MMGB-SA values) of di(2-ethylhexyl)terephthalate (DEHT), tris(2-ethylhexyl)trimellitate (TOTM),
diisononyl hexahydrophthalate (DINCH), and natural ligand, DHT, after Induced Fit Docking with human sex hormone-binding
globulin (SHBG)
S. No. Ligand Number of interacting
residues
Number of interacting residues







1 DEHT 25 18 (82 %) −8.65 −8.65 −130.83
2 TOTM 30 18 (82 %) −9.24 −9.24 −146.21
3 DINCH 30 20 (91 %) −10.16 −10.16 −166.83
4 DHT 22 22 (100 %) −12.02 −12.02 −129.89
Table 3 Amino-acid residues of human sex hormone-binding
globulin (SHBG) that were common among co-complex natural
ligand, dihydrotestosterone (DHT), and alternate plasticizers,
di(2-ethylhexyl)terephthalate (DEHT), tris(2-ethylhexyl)trimellitate





1 Thr-40 11 Asn-82
2 Ser-41 12 Val-105
3 Ser-42 13 Lys-106
4 Phe-56 14 Met-107
5 Gly-58 15 Val-112
6 Asp-59a 16 Ser-128
7 Thr-60 17 Met-139
8 Trp-66b 18 ILe-141
9 Phe-67 19 Leu-171
10 Leu-80
Amino-acid residue indicated by superscript (a) was not shared by DEHT and
the residue indicated by superscript (b) was not shared by TOTM
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a preliminary basis, could possibly disrupt the androgen
and estrogen homeostasis of SHBG more potently and
thus, interfere with steroid signaling function.
This study is, to our knowledge, the first structure
based study of alternate plasticizers showing interaction
with human SHBG. Comparative molecular field analysis
(CoMFA) and molecular similarity indices in a compara-
tive analysis (CoMSiA) have been used to show the
binding simulations for a large number of steroid and
non-steroid compounds with human and zebrafish
homolog of SHBG [39, 45–47]. But, none of previous
docking simulation studies apparently included the three
indicated alternate plasticizers DEHT, TOTM, and
DINCH. In addition, to our knowledge, in vitro competi-
tive binding of alternate plasticizers with SHBG has also
not been performed. However, docking studies involving
the three indicated alternate plasticizers with PPARs
have been reported [40, 41]. In the first study [40],
TOTM was not found to fit into the receptor binding
pocket of PPAR-α and -γ and, therefore, failed to inter-
act with PPAR receptors suggesting TOTM to be a safer
alternative to phthalate plasticizers. In the subsequent
study [41], DEHT, TOTM, and DINCH were reported to
have varied in silico binding ranging from no binding to
very weak binding with PPARs, again suggesting a low
potential risk of endocrine disruption. However, PPARs
are only one of the several possible ways through which
the EDCs can exert their action in the human body [1].
Other enzymatic, nonnuclear receptor, and binding pro-
tein pathways (including that of SHBG) regulating the
development and function of male and female repro-
ductive system have also been proposed to mediate the
endocrine disrupting activity [1, 48]. Additionally, even
though the parent compound may not apparently show
any prediction for potential side effects, yet, it may be
the metabolites of the compounds that are potent endo-
crine disruptors. For example, in a recent study [49], rat
primary stromal vascular fraction (SVF) of adipose tissue
did not show any differentiation on treatment with
DINCH. However, treatment with MINCH (monoester
metabolite of the DINCH) induced the differentiation of
SVF preadipocytes into mature adipocytes indicating
MINCH to be a potent disruptor of PPAR-α. Further,
the interactions of even the weakly bound EDCs with
SHBG may be of high physiological importance espe-
cially during the prepubescent period when estradiol and
testosterone levels are low [50, 51] and during pregnancy
[52] or when taking medications (use of contraceptives
[53]) when SHBG levels are high. These EDCs even in
low levels can bind to greater available binding sites of
SHBG and interfere in hormone homeostasis and bio-
availability of estrogens and androgens. In this regard, it
is of high importance to perform in vitro binding studies
as well as endogenous steroid displacement studies for
the three indicated alternate plasticizers with human
SHBG to confirm and support the in silico findings of
high binding affinity in the present study. In addition,
future in vivo studies in laboratory animals such as mice
on the clearance rate and ovarian and testicular accumu-
lation of the labelled compounds in response to human
SHBG are also suggested.
The current study is an attempt to understand the mo-
lecular interactions of alternate plasticizers with human
SHBG and to help in predicting the risk of potential dis-
ruption in the steroid homeostasis of the human body.
Limited experimental studies on the toxicology of the
three indicated alternate plasticizers are available [10, 11,
13, 54] and epidemiological and clinical studies on the
indicated alternate plasticizers are almost negligible.
However, due to the prohibitions and increasing restric-
tions on the use of phthalate plasticizers, there is an in-
creasing utilization of the indicated alternate plasticizers
for the industrial and personal use. This is evidenced by
the increased volume of the production of these com-
pounds and increased applications in children’s products
in recent years [11]. The increased environmental con-
tamination and exposure risks with alternate plasticizers
were indicated by studies that have shown an increasing
detection rate of plasticizers such as DINCH in adult
volunteers from 0 % in 2007 to 21 % in 2012 [33] in the
USA. Similarly, detection rate of DINCH metabolites in-
creased from 0 % samples during 1999–2003 to 98 %
samples in 2012 in 300 urine samples from the German
Environmental Specimen Bank [34]. Although, the avail-
able limited studies indicate a low toxicological profile of
the indicated three alternate plasticizers, there is a lack
of definitive information regarding the metabolic path-
ways, carcinogenic profile and endocrine disruption risk.
In order to help allay increasing fears of the risks sur-
rounding alternate plasticizers, we would recommend
more experimental studies to unravel the pathways of ex-
posure, more data on human exposure with information
on the adverse effects on highly susceptible demographic
groups such as pregnant women, infants and children, and
an overall safety assessment comparing alternative plasti-
cizers to traditional phthalate plasticizers. As the use of
alternate plasticizers becomes more widespread, the po-
tential risks will increase suggesting that further studies
must be conducted as a matter of urgency.
Conclusions
The present structural binding study on DEHT, TOTM,
and DINCH was expected to help in predicting potential
endocrine disrupting risks of the three alternate plasti-
cizers against SHBG. Induced Fit Docking of three alter-
nate plasticizer compounds indicated that each of the
three compounds fitted well into the steroid binding
pocket of SHBG. About 82–91 % of the SHBG interacting
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residues for the bound ligand, DHT, overlapped with
SHBG interacting residues for the three alternate plasti-
cizers. The hydrogen-bonding interaction of the amino-
acid residue, Asn-82, of SHBG was also present in
displays of DHT and all the three alternate phthalates.
The Dock score and Glide score were highest in DHT
and progressively decreased for DINCH, TOTM, and
DEHT. However, the three alternate plasticizers showed
high binding affinity with SHBG that was higher than
that for the native bound ligand, DHT, indicating more
tight interactions with the SHBG. Thus, on a prelimin-
ary basis, there is a high risk of these alternate plasti-
cizers i.e. DEHT, TOTM, and DINCH binding to the
SHBG in the circulation and potentially displacing the
endogenous testosterone and estradiol leading to po-
tential disruption of the androgen-estrogen homoeosta-
sis in the body.
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